Power up RNA Therapeutics with Early Formulation Screening for Customized Lipid Nanoparticle Solutions

Getting new RNA therapeutics off the ground is challenging. With countless nanoparticle formulation options, researchers need a faster way to identify candidates that deliver nucleic acids efficiently and consistently. Traditional approaches are slow, resource-heavy, and often fail to highlight the best performers.

Early formulation screening changes the game. Using scalable, high-throughput tools like Sunscreen and Sunshine, Merck helps researchers explore a wide range of ionizable lipids, pinpoint top performers, and fine-tune key parameters—all while saving time and reducing complexity. This approach accelerates RNA drug development with customized LNP formulations that improve delivery efficiency and therapeutic outcomes.